Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-31

Clinical Trial Update: Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating low-dose pethidine for subarachnoid anesthesia and a ropivacaine-fentanyl combination for urologic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)
  • Ropivacaine (Ropivacaine)
  • pethidine (meperidine)

Snippet

Sponsor: Saint Savvas Anticancer Hospital | Conditions: Low Dose of Pethidine for Subarachnoid Anesthesia | Phase 2, Phase 3 | Status: COMPLETED